Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026

Same author

Modeling the cost-effectiveness of the COVID-19 mRNA-1273 vaccine in the United States.

Journal of medical economics·2026

Same author

Comparative Effectiveness of mRNA-1273 Versus Protein-Based NVX-CoV2705 Vaccination on COVID-19-Related Outcomes Among Insured Adults in the United States During 2024-2025: A Retrospective Matched Cohort Study.

Advances in therapy·2026

Same author

Incidence of COVID-19 and Influenza-Related Outcomes and Vaccinations in the United States, October 2022 Through December 2024.

Vaccines·2026

Same author

The differences in CT findings between schwannoma in mediastinum and retroperitoneum.

Medicine·2026

Same author

The cost-effectiveness of vaccination against COVID-19 in at-risk populations and older adults in the United Kingdom: Projections using a dynamic transmission model.

Vaccine·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

Accelerating Molecular Dynamics Simulations for Drug Discovery.

Kushal Koirala¹, Keya Joshi¹, Victor Adediwura¹

¹Computational Biology Program and Department of Molecular Biosciences, The University of Kansas, Lawrence, KS, USA.

Methods in Molecular Biology (Clifton, N.J.)

|September 7, 2023

Summary

This summary is machine-generated.

Gaussian accelerated molecular dynamics (GaMD) methods, specifically ligand GaMD (LiGaMD) and LiGaMD2, enhance sampling for drug design. These methods efficiently capture protein-ligand binding and unbinding events, enabling simultaneous thermodynamic and kinetic characterization.

Keywords:

Enhanced sampling Kinetics Ligand Gaussian accelerated molecular dynamics (LiGaMD)Ligand binding and unbinding

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jul 17, 2025

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Computational chemistry
Drug discovery
Molecular dynamics simulations

Background:

Accurate prediction of ligand binding thermodynamics and kinetics is essential for effective drug design.
Conventional molecular dynamics (MD) simulations face significant sampling challenges, hindering the accurate characterization of protein-ligand interactions.
Enhanced sampling methods are needed to overcome these limitations.

Purpose of the Study:

To review the application of ligand Gaussian accelerated molecular dynamics (LiGaMD) in drug discovery.
To outline the usage of LiGaMD and its advanced version, LiGaMD2, for improved protein-ligand interaction sampling.
To demonstrate the capability of LiGaMD methods in characterizing ligand binding thermodynamics and kinetics.

Main Methods:

Utilizing Gaussian accelerated molecular dynamics (GaMD), a method that adds a harmonic boost to overcome energy barriers.
Applying selective boost potentials to ligand nonbonded potential energy (LiGaMD) to enhance sampling of binding and dissociation.
Implementing LiGaMD2 with boost potentials applied to both ligand and surrounding protein residues for increased sampling efficiency.

Main Results:

LiGaMD and LiGaMD2 simulations successfully captured repetitive ligand binding and unbinding events within microsecond timescales.
These enhanced sampling methods significantly improved the exploration of protein-ligand interactions compared to conventional MD.
Simultaneous characterization of both ligand binding thermodynamics and kinetics was achieved.

Conclusions:

LiGaMD and LiGaMD2 represent powerful tools for accelerating drug discovery by overcoming sampling limitations in molecular dynamics.
These methods facilitate the efficient and simultaneous determination of ligand binding thermodynamics and kinetics.
The application of LiGaMD is expected to greatly facilitate and expedite the drug design process.